TY - JOUR
T1 - Does testing for sleep-disordered breathing predischarge vs postdischarge result in different treatment outcomes?
AU - Orbea, Cinthya Pena
AU - Jenad, Hussam
AU - Kassab, Lena Lea
AU - St Louis, Erik K.
AU - Olson, Eric J.
AU - Shaughnessy, Gaja F.
AU - Peng, Lillian T.
AU - Morgenthaler, Timothy I.
N1 - Funding Information:
All authors have seen and approved this manuscript. Work for this study was performed at Mayo Clinic, Rochester, MN. This study was funded by Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Timothy I. Morgenthaler has consulted for Respicardia, Inc., and Withings. The other authors report no conflicts of interest.
Publisher Copyright:
Copyright 2022 American Academy of Sleep Medicine. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Study Objectives: Treatment of sleep-disordered breathing may improve health-related outcomes postdischarge. However timely definitive sleep testing and provision of ongoing therapy has been a challenge. Little is known about how the time of testing—during hospitalization vs after discharge—affects important outcomes such as treatment adherence. Methods: We conducted a 10-year retrospective study of hospitalized adults who received an inpatient sleep medicine consultation for sleep-disordered breathing and subsequent sleep testing. We divided them into inpatient and outpatient sleep testing cohorts and studied their clinical characteristics, follow-up, positive airway pressure adherence, pressure adherence, hospital readmission and mortality. Results: Of 485 patients, 226 (47%) underwent inpatient sleep testing and 259 (53%) had outpatient sleep testing. The median age was 68 years old (interquartile range = 57–78), and 29.6% were females. The inpatient cohort had a higher Charlson Comorbidity Index (4 [3–6] vs 3[2–5], P ≤ .0004). A higher Charlson Comorbidity Index (hazard ratio = 1.14, 95% confidence interval:1.03–1.25, P = .001), body mass index (hazard ratio = 1.03, 95% confidence interval:1.0–1.05, P = .008), and stroke (hazard ratio = 2.22, 95% confidence interval:1.0–4.9, P = .049) were associated with inpatient sleep testing. The inpatient cohort kept fewer follow-up appointments (39.90% vs 50.62%, P = .03); however positive airway pressure adherence was high among those keeping follow-up appointments (88.9% [inpatient] vs 85.71% [outpatient], P = .55). The inpatient group had an increased risk for death (hazard ratio: 1.82 95% confidence interval 1.28–2.59, P ≤ .001) but readmission rates did not differ. Conclusions: Medically complex patients were more likely to receive inpatient sleep testing but less likely to keep follow-up, which could impact adherence and effectiveness of therapy. Novel therapeutic interventions are needed to increase sleep medicine follow-up postdischarge, which may result in improvement in health outcomes in hospitalized patients with sleep-disordered breathing.
AB - Study Objectives: Treatment of sleep-disordered breathing may improve health-related outcomes postdischarge. However timely definitive sleep testing and provision of ongoing therapy has been a challenge. Little is known about how the time of testing—during hospitalization vs after discharge—affects important outcomes such as treatment adherence. Methods: We conducted a 10-year retrospective study of hospitalized adults who received an inpatient sleep medicine consultation for sleep-disordered breathing and subsequent sleep testing. We divided them into inpatient and outpatient sleep testing cohorts and studied their clinical characteristics, follow-up, positive airway pressure adherence, pressure adherence, hospital readmission and mortality. Results: Of 485 patients, 226 (47%) underwent inpatient sleep testing and 259 (53%) had outpatient sleep testing. The median age was 68 years old (interquartile range = 57–78), and 29.6% were females. The inpatient cohort had a higher Charlson Comorbidity Index (4 [3–6] vs 3[2–5], P ≤ .0004). A higher Charlson Comorbidity Index (hazard ratio = 1.14, 95% confidence interval:1.03–1.25, P = .001), body mass index (hazard ratio = 1.03, 95% confidence interval:1.0–1.05, P = .008), and stroke (hazard ratio = 2.22, 95% confidence interval:1.0–4.9, P = .049) were associated with inpatient sleep testing. The inpatient cohort kept fewer follow-up appointments (39.90% vs 50.62%, P = .03); however positive airway pressure adherence was high among those keeping follow-up appointments (88.9% [inpatient] vs 85.71% [outpatient], P = .55). The inpatient group had an increased risk for death (hazard ratio: 1.82 95% confidence interval 1.28–2.59, P ≤ .001) but readmission rates did not differ. Conclusions: Medically complex patients were more likely to receive inpatient sleep testing but less likely to keep follow-up, which could impact adherence and effectiveness of therapy. Novel therapeutic interventions are needed to increase sleep medicine follow-up postdischarge, which may result in improvement in health outcomes in hospitalized patients with sleep-disordered breathing.
KW - follow-up studies
KW - inpatient
KW - patient discharge
KW - patient readmission
KW - sleep-disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=85122489291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122489291&partnerID=8YFLogxK
U2 - 10.5664/jcsm.9450
DO - 10.5664/jcsm.9450
M3 - Article
C2 - 34216199
AN - SCOPUS:85122489291
SN - 1550-9389
VL - 17
SP - 2451
EP - 2460
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 12
ER -